Food, Drugs, Healthcare, Life Sciences

In an era of rapid food industry development, the demand for clear and understandable nutritional information on food packaging is growing.

This afternoon, the U.S. Department of Commerce (Commerce) released notice of an investigation under Section 232 of the Trade Expansion Act of 1962 into the effect of imported pharmaceuticals, pharmaceutical ingredients, and their derivative products on U.S. national security.

NAFDAC refers to the National Agency for Food and Drug Administration and Control, the government regulatory agency charged with regulating and controlling the manufacture, importation, exportation, distribution...

The U.K. Government has announced the creation of a new U.K-wide Health Data Research Service that will provide a secure single access point to national-scale data sets.

In an era of rapid food industry development, the demand for clear and understandable nutritional information on food packaging is growing.

This afternoon, the U.S. Department of Commerce (Commerce) released notice of an investigation under Section 232 of the Trade Expansion Act of 1962 into the effect of imported pharmaceuticals, pharmaceutical ingredients, and their derivative products on U.S. national security.

In January 2025, FDA posted the 2024 Annual Report concerning the Accreditation Scheme for Conformity Assessment (ASCA) program as required by Medical Device User Fee Amendments of 2017 (MDUFA IV).

NAFDAC refers to the National Agency for Food and Drug Administration and Control, the government regulatory agency charged with regulating and controlling the manufacture, importation, exportation, distribution...

An employee from a commercial cleaning company was sentenced to two months in prison for obstructing an antitrust investigation by destroying and concealing documents during a police raid in Hong Kong.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.